| BATS | 5.36% | 4,146.0 | -1.59% | 2,178,097 | |
| SIEGn | 3.71% | 236.85 | +1.65% | 327,865 | |
| NOVN | 3.55% | 101.54 | -0.43% | 668,040 | |
| SASY | 2.96% | 85.36 | -1.36% | 698,742 | |
| HSBA | 2.83% | 955.80 | +0.17% | 5,217,822 | |
| SAN | 2.50% | 8.2350 | +2.13% | 6,243,954 | |
| SGEF | 2.01% | 117.10 | +1.21% | 322,301 | |
| GSK | 1.95% | 1,459.50 | -1.18% | 2,329,488 | |
| IFXGn | 1.91% | 36.315 | +1.16% | 1,089,519 | |
| BNPP | 1.84% | 76.90 | +0.48% | 458,693 |
iShares IV Public Limited Company - iShares Edge MSCI Europe Value Factor UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. It is managed by BlackRock Advisors (UK) Limited. The fund invests in the public equity markets of developed countries in Europe. It seeks to invest in the stocks of companies operating across diversified sectors. The fund invests in the value stocks of large-cap and mid-cap companies. It seeks to replicate the performance of the MSCI Europe Enhanced Value Index, by employing representative sampling methodology. The fund was formerly known as iShares IV Public Limited Company - iShares MSCI Europe Value Factor UCITS ETF. iShares IV Public Limited Company - iShares Edge MSCI Europe Value Factor UCITS ETF was formed on January 16, 2015 and is domiciled in Ireland.